Such cells control aggressive immune cells and, thus, unwanted immune reactions by the graft can be avoided. However, to date, there were no adequate techniques available to securely isolate the regulatory T cells.
Now, researchers of the Max Delbrück Center (MDC), Germany and their colleagues of the 'Fondazione Santa Lucia' in Rome, Italy have developed a simple method to specifically isolate these cells from human blood. (Blood)*.
According to the American Cancer Society, about 188,000 people world-wide developed leukaemia in 2007. Predominantly immature white blood cells can be found in their blood. These cells displace the healthy cells and, thus, suppress Blood a normal haematopoiesis. Chemotherapy destroys the diseased cells of the patient which then often have to be replaced by a bone marrow graft.
"However," says Dr. Markus Kleinewietfeld (MDC), "in 30 to 50 percent of the patients, the aggressive immune cells contaminating the bone marrow graft direct themselves against the recipient." This often lethal defence reaction is called 'Graft versus Host Disease' (GvHD). Yet, with the help of regulatory T cells from the blood of the donor, the rejection reaction might be suppressed.
"Until now, it was not possible to securely isolate regulatory T cells in their pure form," explains Dr. Kleinewietfeld. Since, in humans, the cell surface marker (CD25) used for the isolation before is also found on the aggressive immune cells, it was hardly possible to clearly separate the helpful Tregs from the dangerous cells.
With other markers (CD49d and CD127), the scientists now succeeded in separating the aggressive and dangerous immune cells from the helpful, regulatory cells. Thus, it is now possible to isolate regulatory T cells in high purity safely from human blood. Using these T cells, the researchers could already suppress a particular severe form of the 'Graft versus Host Disease' in mice. In a first clinical trial in Singapore, the MDC researchers now want to apply the regulatory cells in leukaemia patients who developed the severe immune reaction after a bone marrow donation.
"Singapore provides the infrastructure and financial commitment necessary for such trials," says Dr. Olaf Rötzschke, a former MDC researcher who now works at the 'Singapore Immunology Network' (SIgN) of the BIOPOLIS Campus. "Dependent on the outcome of this clinical test, regulatory T cells could possibly be used also for the treatment of autoimmune diseases, allergies and tissue rejections in the future," hopes Dr. Kirsten Falk, head of the MDC research group.
*Blood: doi 10 1182/blood-2008-04-150524
CD49d provides access to 'untouched' human Foxp3+ Treg free of contaminating effector cells
Markus Kleinewietfeld1, Mireille Starke1, Diletta Di Mitri2, Giovanna Borsellino2, Luca Battistini2, Olaf Rötzschke1,3, Kirsten Falk11Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, D-13125 Berlin, Germany
3Singapore Immunology Network (SIgN), 8A Biomedical Grove, IMMUNOS, Singapore 138648, SingaporeBarbara Bachtler
Barbara Bachtler | idw
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences